eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | ankylosing spondylitis |
| Symptom | C0948265|metabolic syndrome |
| Sentences | 2 |
| PubMedID- 23484462 | Objectives: to determine whether disease activity, systemic inflammation and metabolic syndrome are potential determinants of circulating apelin in ankylosing spondylitis (as) patients undergoing tnf-alpha antagonist-infliximab therapy. |
| PubMedID- 24757680 | Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. |
Page: 1